Serum fructosamine in the assessment of glycaemic control in diabetes mellitus

1987 ◽  
Vol 47 (3) ◽  
pp. 285-292 ◽  
Author(s):  
P. Koskinen ◽  
K. Irjala ◽  
J. Viikari ◽  
R. Panula-Ontto ◽  
M. -T. Matikainen
2002 ◽  
Vol 43 (2) ◽  
pp. 67-73 ◽  
Author(s):  
P. A. GRAHAM ◽  
I. E. MASKELL ◽  
J. M. RAWLINGS ◽  
A. S. NASH ◽  
P. J. MARKWELL

2021 ◽  
Author(s):  
Martin R Cowie

Tweetable abstract Sodium–glucose cotransporter-2 inhibitors not only improve glycaemic control in Type 2 diabetes mellitus but convincingly improve outcome for everyone with HFrEF and albuminuric kidney disease. Trials then license – now all we need is implementation


Sign in / Sign up

Export Citation Format

Share Document